Biosimilars Are Effective and Safe in Treating Psoriasis Biosimilars Are Effective and Safe in Treating Psoriasis
An analysis of clinical studies that compared approved biological drugs with their biosimilar counterparts has failed to find clinically meaningful differences in efficacy and adverse events.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 5, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Study Evaluates Pregnancy Risks With Biologics for Psoriasis Study Evaluates Pregnancy Risks With Biologics for Psoriasis
Use of biologics to treat psoriasis during pregnancy and/or at the time of conception was not associated with a higher rate of miscarriages or birth defects in a new meta-analysis.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 3, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Review Finds Biosimilars for Psoriasis Safe, Effective Review Finds Biosimilars for Psoriasis Safe, Effective
' Switching patients currently on originators to biosimilars could be considered where clinically appropriate to reduce treatment costs, ' the authors concluded.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 30, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Hepatitis B Vaccination Rates Lag in Patients With Psoriasis Hepatitis B Vaccination Rates Lag in Patients With Psoriasis
Vaccination rates for hepatitis B virus are slightly lower among patients with psoriasis than among people without psoriasis.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 27, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
FDA Decision on Bimekizumab Approval for Psoriasis Delayed FDA Decision on Bimekizumab Approval for Psoriasis Delayed
The agency ' s review of bimekizumab for moderate to severe psoriasis is continuing through the third quarter of this year, the manufacturer announced.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 27, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
FDA OKs Ritlecitinib for Ages 12 and Up for Alopecia Areata FDA OKs Ritlecitinib for Ages 12 and Up for Alopecia Areata
The approval follows the approval of the JAK inhibitor baricitinib for alopecia areata in adults in 2022.News Alerts (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 24, 2023 Category: Dermatology Tags: Dermatology News Alert Source Type: news
New Laser Improves Birthmarks With Fewer Treatments New Laser Improves Birthmarks With Fewer Treatments
The mean maximum spot size of the novel-generation pulsed dye laser is 13.1 mm compared with a mean spot size of 10.8 mm with the prior-generation pulsed dye laser.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 23, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Hairy Moles May Contain the Cure for Baldness: Study Hairy Moles May Contain the Cure for Baldness: Study
Researchers may have discovered the elusive cure to baldness in an unlikely place: those unsightly hairs that sometimes grow out of skin moles.WebMD Health News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 22, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
SCC in Transplant Recipients: Prognostic Features Identified SCC in Transplant Recipients: Prognostic Features Identified
The findings build on previous research and underscore the need for early diagnosis and aggressive surveillance in this patient population, the authors write.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 21, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Methotrexate Does Not Impair Sperm Quality Methotrexate Does Not Impair Sperm Quality
The findings provide reassurance that men can start methotrexate therapy while actively pursuing parenthood.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 17, 2023 Category: Dermatology Tags: Rheumatology News Source Type: news
FDA Warns of Tattoo Ink Tied to Dangerous Infections FDA Warns of Tattoo Ink Tied to Dangerous Infections
"I ' ve seen several different infections from tattooing, and they are from organisms that tend to contaminate things in damp, liquid-type environments."WebMD Health News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 16, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Lupus Trials: What's Key to Lowering Placebo Response Rates? Lupus Trials: What's Key to Lowering Placebo Response Rates?
High placebo response rates in lupus clinical trials are making it difficult to show treatment effectiveness.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 15, 2023 Category: Dermatology Tags: Rheumatology News Source Type: news
EULAR Lupus Recommendations: Use Biologics, Taper Steroids EULAR Lupus Recommendations: Use Biologics, Taper Steroids
The 2023 recommendations cover new treatment strategies with more ambitious goals, new data on adverse effects of chronic glucocorticoid use, and newly approved agents and combination therapies.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 14, 2023 Category: Dermatology Tags: Rheumatology News Source Type: news
Crohn's Associated With HS in Kids, Analysis Suggests Crohn's Associated With HS in Kids, Analysis Suggests
The low absolute prevalence of Crohn ' s disease among pediatric patients with hidradenitis suppurativa"is reassuring," the researchers write.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 14, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Complications With MED Treatment of Hyperhidrosis Reported Complications With MED Treatment of Hyperhidrosis Reported
Adverse events reported to the FDA included infections, neurological symptoms, and burns, the review found.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 14, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
